PALISADE BIO, INC. — Director's Dealing 2015

Nov 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-11-19

Reporting Person: JOHE KARL (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-19	Common Stock	M	143247	—	Acquired	969551	Direct
2015-11-19	Common Stock	F	39178	$1.14	Disposed	930373	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-19	Restricted Stock Unit	$	M	143247	Disposed		Common Stock (143247)	Direct

Footnotes

F1: Represents the conversion of restricted stock units into Common Stock. On November 19, 2015, the reporting person was granted 143,247 shares of Common Stock, of which 39,178 shares were forfeited for tax withholding purposes.

F2: 23,874 Shares of Common Stock issued upon conversion of the restricted stock units are being held as collateral for the payment of Reporting Person's divorce settlement.

F3: Each restricted stock unit represents a right to receive one share of Neuralstem's Common Stock.